Bas L. van der Hoeven

Showing 1-3 of 3 articles

Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients

Velders M, Boden H, van der Hoeven B, Liem S-S, Atary J, van der Wall E, Jukema J, Schalij M

February 22, 2013 | 10.4244/EIJV8I10A184

Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial

Boden H, van der Hoeven B, Liem S-S, Atary J, Cannegieter S, Atsma D, Bootsma M, Jukema J, Zeppenfeld K, Oemrawsingh P, van der Wall E, Schalij M

January 20, 2012 | 10.4244/EIJV7I9A164

Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study

Atary J, Bergheanu S, van der Hoeven B, Atsma D, Bootsma M, van der Kley F, Zeppenfeld K, Jukema J, Schalij M

November 15, 2009 | 10.4244/EIJV5I5A92

1

Latest news

The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...

December 18, 2020

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Addressing interventional periprocedural anxiety with virtual reality

January 13, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Translating ISCHEMIA into practice

William E. Boden

January 13, 2021

This Week's JAA's: BIOFREEDOM-QCA trial, TTVr with the TriClip/MitraClip G4 System, Numerical prediction of coronary artery compression in TPVI...

January 12, 2021

Valvular disease